{"nct_id":"NCT02325791","title":"Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants","status":"COMPLETED","status_verified_date":"2018-10","start_date":"2015-07-21","start_date_type":null,"primary_completion_date":"2017-07-05","primary_completion_date_type":"ACTUAL","completion_date":"2017-09-26","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["REGN"]}